Skip to main content
Download PDF

Prevalence of gonococcal and chlamydial infections among men who have sex with men in sub-Saharan Africa: protocol for a systematic review and meta-analysis

Systematic Reviews volume 12, Article number: 141 (2023) Cite this article

Abstract

Background

Bacterial sexually transmitted infections (STIs) including Neisseria gonorrhoeae and Chlamydia trachomatis are common in men who have sex with men (MSM). These infections increase the risk of acquiring and transmitting human immunodeficiency virus (HIV) in this key population. Access to MSM in many countries in sub-Saharan Africa remains generally difficult due to discrimination or criminalization of their sexual orientation which could lead to depression and risky sexual practices associated with prevalence. This protocol therefore proposes to undertake a systematic review and meta-analysis of literature on the prevalence of gonococcal and chlamydial infections among MSM in Sub-Saharan Africa.

Methods

This review which aims to ascertain the pooled prevalence and risk factors of these infections in sub-Saharan Africa’s MSM population will follow the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) guidelines. The search strategy will review relevant articles from the following databases: PubMed, Scopus, ISI Web of Science and the Directory of Open Access Journals (DOAJ). Articles screening for eligibility and data extraction will be conducted by two independent reviewers. All discrepancies will be resolved by the third and fourth reviewers. Heterogeneity in studies will be evaluated using the I2 statistic and where heterogeneity is high and significant, a random effect model will be used to estimate the pooled prevalence. Publication bias will be assessed using the Doi plot. Extracted data will be analysed using MetaXL add-on for Microsoft excel. Data will be presented in tables and graphically presented in forest plots.

Discussion

In this study, we anticipate being able to systematically determine the prevalence of Neisseria gonorrhoeae and Chlamydia trachomatis among MSM as well as explore possible risk factors associated with prevalence. The outcomes of the systematic review and meta-analyses will serve to support researchers and public health stakeholders in identifying healthcare priorities and in addressing issues pertaining to the overall wellbeing of the MSM community.

Systematic review registration

PROSPERO CRD42022327095

Peer Review reports

Background

Sexually transmitted infections (STIs), including gonorrhoea and chlamydia, cause significant morbidity and mortality worldwide [1]. These STIs are a variety of clinical syndromes caused by pathogens that can easily be transmitted through sexual contact [2] and can facilitate individual susceptibility to human immunodeficiency virus (HIV) acquisition and transmission [1, 3]. Globally, the rate of STIs is increasing despite biomedical advances and considerable public health efforts. In 2012, 498.9 million new cases of curable STIs were reported worldwide. Their burden is disproportionally higher in low- and middle-income countries, with sub-Saharan Africa contributing 93 million new cases [4, 5]. Vulnerable populations include men who have sex with men (MSM) [6].

Studies on MSM in sub-Saharan Africa have reported high prevalence of STIs including Neisseria gonorrhoea (Ng) and Chlamydia trachomatis (Ct) [7, 8]. These bacterial infections (Ng and Ct) among African MSM have prevalence reportedly ranging from 1% [9] to 23% [10]. Studies from Kenya have shown Ng prevalence among gay men and other MSM to be 9.3% [11]. In Senegal, Ng prevalence among MSM has been estimated at 5.5% [12, 13] while in Nigeria, a published study estimated a Ng prevalence of 23% and Ct prevalence of 16% [14].

Although much attention has been given to African MSM in recent times, access to MSM in many countries in sub-Saharan Africa remains generally difficult. This situation is largely due to stigma, discrimination and/or criminalization of their sexual orientation [15,16,17], leading to their reluctance in accessing healthcare services. Because MSM suffer significant stigma due to lack of social acceptance, they become depressed and may engage in risky sexual practices including alcohol and substance abuse which are associated with prevalence [18,19,20]. Almost two-third of African countries still criminalize same-sex sexual behaviour, with long prison sentences or even the death penalty [21]. These issues may explain why research on MSM in sub-Saharan Africa is lagging behind other parts of the world [22,23,24], contributing to the paucity of information on this key population at higher risk for STIs. Hence, a systematic review aimed at ascertaining the pooled prevalence of Ng and Ct, and their associated risk factors in MSM in sub-Saharan Africa is necessary. The result of which is likely to inform research and policies in identifying healthcare priorities for this population living in Africa.

Objectives

This protocol for a systematic review aims to document the pooled prevalence of infections by Chlamydia trachomatis and Neisseria gonorrhoeae in MSM in sub-Saharan Africa. Other objectives are to:

  • Describe chlamydial and gonococcal infections diagnosed by syndromic management or laboratory testing

  • Identify the associated risk factors for the prevalent infections among MSM

Methods

This protocol is registered with the open access registry for systematic review protocols PROSPERO (CRD42022327095) and developed in accordance with the Preferred Reporting Items for Systematic Review and Meta-analyses for Protocols (PRISMA-P) 2015 checklist [25]. The planned systematic review will be reported according to the PRISMA 2020 statement [26].

Eligibility of research question

A Population Exposure Outcomes (PEO) framework (Table 1) will be used to evaluate the eligibility of the research question. Only studies reporting overall and/or anatomical site-specific prevalence of chlamydia and/or gonorrhoea in men who have sex with men will be included. No restriction will be applied for study design, diagnostic test type and year of publication.

Table 1 PEO (Population, Exposure, Outcomes) framework
Full size table

Identifying relevant studies

Electronic databases will be used to search articles in peer-reviewed journals from the following databases: PubMed, Scopus, ISI Web of Science, Directory of Open Access Journals (DOAJ). Search terms used and their synonyms were identified using the Medical Subject Headings (MeSH). The uniterms and Boolean operators in English to be used in the search strategies are (Men who have sex with men OR gay) AND ((Neisseria gonorrhoeae OR N. gonorrhoeae OR Gonorrhoeae infection OR Gonorrhoeae) AND (Chlamydia trachomatis OR C. trachomatis OR Chlamydia infection OR Chlamydia)) AND (Africa OR Sub-Saharan Africa OR Western Africa OR Eastern Africa OR Southern Africa OR Central Africa). Also, a combination of relevant key words with names of each of the countries in Sub-Saharan Africa will also be performed. The search strategy will be adapted for each of the databases to be searched. The search strategy was piloted in April 2022 to test the appropriateness of selected keywords and electronic databases as depicted in Table 2.

Table 2 Potential search strategy on PubMed
Full size table

Study selection

The selection of eligible studies will be based on the following inclusion and exclusion criteria:

Inclusion criteria

  1. 1.

    Studies that describe data from MSM in sub-Saharan Africa

  2. 2.

    Studies that include men who have sex with men 15 years and older

  3. 3.

    Studies that quantified the prevalence of chlamydia and/or gonorrhoea

  4. 4.

    Original research written in English language

  5. 5.

    Studies that report prevalence based on an adequate numerator and denominator where actual diagnostic tests were employed

Exclusion criteria

  1. 1.

    Studies that assessed non-human subjects

  2. 2.

    Studies published in languages other than English

  3. 3.

    Studies without full text available

  4. 4.

    Studies that computed incident infections only

  5. 5.

    Studies conducted in other countries other than countries in Sub-Saharan Africa

  6. 6.

    Case reports, Short reports, Letters, Notes, Conference abstracts, Review articles

First, title and abstracts of retrieved articles will be screened. Titles and abstracts of all articles identified from the search will be independently screened by the primary author and a co-author, following removal of duplicates. Then, full article screening will be conducted for their eligibility. Eligible articles will be retrieved and exported to Endnote version 20 reference manager. A hand search of the reference list of all selected articles will also be performed in order to be more comprehensive in the search strategy. Disagreements between the two authors (if any) will be discussed and resolved with the third and fourth authors. Full article screening based on eligibility criteria will then be conducted independently by two authors and all discrepancies resolved by the third and fourth authors. The PRISMA flowchart will be used to report the screening results (Fig. 1).

Fig. 1
figure 1

PRISMA flow diagram describing selection of studies for systematic review of gonorrhoea and chlamydia prevalence among MSM in sub-Saharan Africa [26]

Full size image

Data extraction

A data extraction template will be designed using Microsoft Excel for collection of data from eligible studies. This data extraction template will be piloted and edited through an iterative process. Two authors will independently extract the data. The third and fourth author will independently verify all extracted data. The following data will be extracted: first author, year of publication, study period, country, geographic location, study design, setting, type of participants, sampling method, sample size, age, median age, specimen type, anatomical site, laboratory diagnosis method, prevalence of chlamydia and/or gonorrhoeae (Table 3). In case of missing or incomplete information, authors will contact the authors of the publications to request further particulars.

Table 3 Data extraction tool
Full size table

Risk of bias and quality assessment

The risk of bias tool for prevalence studies will be used to evaluate the quality and risk of bias of the included studies for the review and meta-analysis. This tool which was developed by Hoy and colleagues uses a 10-item rating scale to assess the internal and external validity of studies [27]. Each of the 10 items will be rated as either low or high risk of bias and the overall risk of bias will then be determined according to the number of high risk of bias per study (low: ≤2; moderate: 3–4; and high: ≥5) [28]. Insufficient information related to 10 items will be regarded as high risk of bias [29, 30].

The quality of evidence provided by the included studies will be established using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool taking into account the risk of bias, indirectness of evidence, inconsistencies, imprecision and publication bias. Following assessment, the overall certainty in evidence will be categorized into four: High (the true effect is similar to the estimated effect), Moderate (where the true effect is probably close to the estimated effect), Low (where the true effect might be markedly different from the estimated effect) and Very low (where the true effect is probably markedly different from the estimated effect).

Data synthesis and analysis

The extracted data will be analysed using the MetaXL add-on for Microsoft excel [31, 32]. The data will be presented using tables and the results will be graphically presented in forest plots. The heterogeneity in the studies will be evaluated using the I2 statistic. Where heterogeneity is high and significant across the included studies, a random effect model will be used to determine the pooled prevalence estimate. Subgroup analysis and meta-regression will be conducted to detect possible sources of heterogeneity according to study characteristics such as study design, sample size, country, diagnostic test and HIV status. Publication bias will be assessed using the Doi plot [33].

Discussion

In this study, we expect to be able to systematically determine the prevalence of Ng and Ct among MSM. Furthermore, we will explore possible risk factors associated with prevalence. The results section of the systematic review and meta-analysis will include a description of all studies, results of all analyses including planned subgroup analyses. We will in the discussion section summarize the main findings and their implications. We will also compare our findings with others and discuss limitations of the study.

This study is necessary and of importance considering that STIs remain a major public health problem in Africa, and the role of MSM in the transmission dynamics is increasingly being recognized [34]. Published estimates indicate that Africa remains the continent most affected by STI/HIV [35]. MSM, particularly those from Africa, are at increased risk for STIs such as HIV, Ng, Ct and syphilis [34, 36, 37] and may experience significant barriers to quality health care due to widespread sigma, criminalization [38] and ridicule by healthcare workers [22]. This situation is compounded by the general lack of data on MSM prevalence of STI/HIV and risk factors in the African setting [34, 35]. Therefore, in order to adequately address and contain the STI epidemic and the associated burden in this key population, more research is required.

The outcomes of the systematic review and meta-analyses will be disseminated through publication in peer-reviewed journals. The findings of this study will serve to support researchers and public health stakeholders in identifying healthcare priorities and in addressing issues pertaining to the overall wellbeing of the MSM population.

Availability of data and materials

All data generated or analysed during this investigation will be included in the published systematic review article and will be available upon request.

Abbreviations

STIs:

Sexually transmitted infections

HIV:

Human immunodeficiency virus

MSM:

Men who have sex with men

Ng:

Neisseria gonorrhoeae

Ct:

Chlamydia trachomatis

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-analyses

PRISMA-P:

Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols

PEO:

Population Exposure Outcomes

DOAJ:

Directory of Open Access Journals

MeSH:

Medical Subject Headings

GRADE:

Grading of Recommendations, Assessment, Development and Evaluation

References

  1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. De Schryver A, Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ. 1990;68(5):639–54.

    PubMed  PubMed Central  Google Scholar 

  3. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2(1):33–42.

    Article  CAS  PubMed  Google Scholar 

  4. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections. 2012. https://apps.who.int/iris/bitstream/handle/10665/75181/9789241503839_eng.pdf?sequence=1. Accessed 17 Feb 2022 .

    Google Scholar 

  5. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.

    Article  PubMed  PubMed Central  Google Scholar 

  6. World Health Organization. Report on global sexually transmitted infection surveillance 2018. 2018. https://www.who.int/publications/i/item/9789241565691. Accessed 17 Feb 2022 .

    Google Scholar 

  7. Wade AS, Kane CT, Diallo PA, et al. HIV infection and sexually transmitted infections among men who have sex with men in Senegal. AIDS. 2005;19(18):2133–40.

    Article  PubMed  Google Scholar 

  8. Vuylsteke B, Semde G, Sika L, et al. High prevalence of HIV and sexually transmitted infections among male sex workers in Abidjan, Cote d’Ivoire: need for services tailored to their needs. Sex Transm Infect. 2012;88(4):288–93.

    Article  PubMed  Google Scholar 

  9. Quilter LAS, Obondi E, Kunzweiler C, et al. Prevalence and correlates of and a risk score to identify asymptomatic anorectal gonorrhoea and chlamydia infection among men who have sex with men in Kisumu Kenya. Sex Transm Infect. 2019;95(3):201–11.

    Article  PubMed  Google Scholar 

  10. Ramadhani HO, Liu H, Nowak RG, et al. Sexual partner characteristics and incident rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections among gay men and other men who have sex with men (MSM): a prospective cohort in Abuja and Lagos Nigeria. Sex Transm Infect. 2017;93(5):348–55.

    Article  PubMed  Google Scholar 

  11. Buve A, Weiss HA, Laga M, et al. The epidemiology of gonorrhoea, chlamydial infection and syphilis in four African cities. AIDS. 2001;15(4):S79-88.

    Article  PubMed  Google Scholar 

  12. Ndiaye AG, Faye CM, Ndiaye I, et al. Screening for HIV, Syphilis, Chlamydia trachomatis and Neisseria gonorrhoeae during a combined survey conducted in Malicouna, a Senegalese rural area. Bull Soc Pathol Exot. 2009;102(3):150–4.

    PubMed  Google Scholar 

  13. Wade AS, Larmarange J, Diop AK, et al. Reduction in risk-taking behaviours among MSM in Senegal between 2004 and 2007 and prevalence of HIV and other STIs. ELIHoS Project, ANRS 12139. AIDS Care. 2010;22(4):409–14.

    Article  PubMed  Google Scholar 

  14. Keshinro B, Crowell TA, Nowak RG, et al. High prevalence of HIV, chlamydia and gonorrhoea among men who have sex with men and transgender women attending trusted community centres in Abuja and Lagos, Nigeria. J Int AIDS Soc. 2016;19(1):21270.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hessou PHS, Glele-Ahanhanzo Y, Adekpedjou R, et al. Comparison of the prevalence rates of HIV infection between men who have sex with men (MSM) and men in the general population in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2019;19(1):1634.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Baral S, Trapence G, Motimedi F, et al. HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS One. 2009;4(3):e4997.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Graham SM, Mugo P, Gichuru E, et al. Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high- risk sexual behaviour, including men who have sex with men, in coastal Kenya. AIDS Behav. 2013;17(4):1255–65.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tafuma TA, Merrigan MB, Okui LA, Lebelonyane R, Bolebantswe J, Mine M, Chishala S, Moyo S, Thela T, Rajatashuvra A. HIV/sexually transmitted infection prevalence and sexual behaviour of men who have sex with men in 3 districts of Botswana: results from the 2012 Biobehavioural Survey. Sex Transm Dis. 2014;41(8):480–5.

    Article  PubMed  Google Scholar 

  19. Dudareva-Vizule S, Haar K, Sailer A, et al. Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect. 2014;90(1):46–51.

    Article  PubMed  Google Scholar 

  20. Rebe K, Lewis D, Myer L, et al. A cross sectional analysis of gonococcal and chlamydial infections among men-who-have-sex-with-men in Cape Town, South Africa. PLoS One. 2015;10(9):e0138315.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Carroll A, Mendos LR. State sponsored homophobia 2017: a world survey of sexual orientation laws: criminalisation, protection and recognition. 12th ed. International Lesbian, Gay, Bisexual, Trans and Intersex Association (ILGA); 2017. https://www.ecoi.net/en/file/local/1399981/90_1495430692_ilga-state-sponsored-homophobia-2017-web-corr.pdf. Accessed 7 Apr 2022.

  22. Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet. 2009;374(9687):416–22.

    Article  PubMed  Google Scholar 

  23. Poteat T, Diouf D, Drame FM, et al. HIV risk among MSM in Senegal: a qualitative rapid assessment of the impact of enforcing laws that criminalize same sex practices. PLoS One. 2011;6(12):e28760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Beyrer C, Baral SD, Van Griensven F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367–77.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.

    Article  Google Scholar 

  26. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.

    Article  PubMed  Google Scholar 

  28. Tezera R, Sahile Z, Yilma D, et al. Prevalence of anaemia among school-age children in Ethiopia: a systematic review and meta-analysis. Syst Rev. 2018;7(1):80.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Dorsamy V, Bagwandeen C, Moodley J. The prevalence, risk factors and outcomes of anaemia in South African pregnant women: a systematic review and meta-analysis. Syst Rev. 2022;11:16.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Young JJ, Hartvigsen J, Jensen RK, et al. Prevalence of multimorbid degenerative lumbar spinal stenosis with knee and/or hip osteoarthritis: protocol for a systematic review and meta-analysis. Syst Rev. 2020;9(1):232.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8.

    Article  PubMed  Google Scholar 

  32. Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Simulation comparison of the quality effects and random effects methods of meta-analysis. Epidemiology. 2015;26(4):e42-4.

    Article  PubMed  Google Scholar 

  33. Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195–203.

    Article  PubMed  Google Scholar 

  34. Muraguri N, Tun W, Okal J, Broz D, Raymond HF, Kellogg T, Dadabhai S, Musyoki H, Sheehy M, Kuria D, Kaiser R, Geibel S. HIV and STI prevalence and risk factors among male sex workers and other men who have sex with men in Nairobi Kenya. J Acquir Immune Defic Syndr. 2015;68(1):91–6.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Lewis DA. HIV/sexually transmitted infection epidemiology, management and control in the IUSTI Africa region: focus on sub-Saharan Africa. Sex Transm Infect. 2011;87 Suppl 2:ii10-13.

    PubMed  Google Scholar 

  36. World Health Organization. Report on global sexually transmitted infection surveillance 2015. 2006. https://apps.who.int/iris/handle/10665/249553. Accessed 12 Feb 2022.

    Google Scholar 

  37. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2016. United States Department of Health and Human Services. 2017. https://www.cdc.gov/std/stats16/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf. Accessed 26 Jan 2022.

    Google Scholar 

  38. African Medical and Research Foundation (Amref Health Africa). Position statement on MSM. 2017. https://amref.org/position-statements/amrefs-position-statement-on-msm/. Accessed 22 Mar 2022.

    Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. School of Clinical Medicine Laboratory, College of Health Sciences, University of KwaZulu-Natal, KwaZulu-Natal, South Africa

    Kehinde Charles Mofolorunsho & Nathlee Samantha Abbai

  2. School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, KwaZulu-Natal, South Africa

    Vinogrin Dorsamy

  3. School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, KwaZulu-Natal, South Africa

    Chauntelle Bagwandeen

Authors
  1. Kehinde Charles Mofolorunsho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinogrin Dorsamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chauntelle Bagwandeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nathlee Samantha Abbai
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

This systematic review protocol was conceptualized by KCM and NSA. KCM, VD, CB and NSA participated in the design of the study. KCM prepared the original draft and VD, CB and NSA contributed to the review and editing of this protocol. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kehinde Charles Mofolorunsho.

Ethics declarations

Ethics approval and consent to participate

Not applicable. This systematic review will not consist of human participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mofolorunsho, K.C., Dorsamy, V., Bagwandeen, C. et al. Prevalence of gonococcal and chlamydial infections among men who have sex with men in sub-Saharan Africa: protocol for a systematic review and meta-analysis. Syst Rev 12, 141 (2023). https://doi.org/10.1186/s13643-023-02305-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13643-023-02305-2

Keywords

  • Prevalence
  • Men who have sex with men
  • Neisseria gonorrhoeae
  • Chlamydia trachomatis
  • Sub-Saharan Africa

Systematic Reviews

ISSN: 2046-4053